Screener
Generate Biomedicines, Inc. GENB Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | ||
|---|---|---|---|---|---|
| $4.22M— | $6.31M-37.7% | $7.22M-18.1% | $10.13M— | ||
| $82.25M— | $64.33M+7.7% | $57.81M+23.5% | $59.74M— | ||
| $13.47M— | $13.6M+29.0% | $13.52M+33.3% | $10.55M— | ||
| $95.73M— | $77.93M+10.9% | $71.34M+25.2% | $70.28M— | ||
| -$91.51M— | -$71.61M-19.1% | -$64.11M-33.1% | -$60.15M— | ||
| -2,168.4%— | -1,134.2%-540pp | -887.5%-341pp | -593.8%— | ||
| $192K— | $155K-49.5% | $182K-50.5% | $307K— | ||
| $3.9M— | $4.41M+27.8% | $2.43M-37.7% | $3.45M— | ||
| -$87.61M— | -$67.2M-18.5% | -$61.69M-39.4% | -$56.7M— | ||
| $49K— | $53K+20.5% | $28K-50.0% | $44K— | ||
| -$87.66M— | -$67.26M-28.3% | -$61.45M-47.4% | -$52.43M— | ||
| -2,077.2%— | -1,065.2%-548pp | -850.6%-378pp | -517.6%— | ||
| -$0.68— | -$0.52+73.2% | -$1.07+34.0% | -$1.94— | ||
| -$87.81M— | -$68.41M-20.3% | -$60.84M-36.0% | -$56.85M— | ||
| -2,080.7%— | -1,083.5%-522pp | -842.2%-335pp | -561.2%— | ||
| -$91.51M— | -$71.61M-19.1% | -$64.11M-33.1% | -$60.15M— |
FAQ
- Where does Generate Biomedicines, Inc.'s income statement data come from?
- Every line is extracted from Generate Biomedicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.